http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015199677-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a98cb1b197f761c87cd3caf32bc247e2 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate | 2014-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_929460492bc83767c6d76cd5ed7358cf |
publicationDate | 2015-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2015199677-A |
titleOfInvention | Antitumor agent and antitumor effect potentiator containing nogitecan hydrochloride |
abstract | [Problem] To provide a novel cancer therapeutic compounding agent and a therapeutic method which exhibit a remarkably excellent antitumor effect and have few side effects. An antitumor agent comprising a combination of an antitumor effect potentiator containing trifluridine and tipiracil hydrochloride at a molar ratio of 1: 0.5 and nogitecan hydrochloride. [Selection figure] None |
priorityDate | 2014-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 338.